Live Breaking News & Updates on Presentation Details|Page 1

Stay updated with breaking news from Presentation details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

G1 Therapeutics Announces Upcoming Presentation at the 2024

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting. ....

United States , American Society Of Clinical Oncology , Research Triangle Park , Exchange Commission , Corporate Communications , Therapeutics Inc , Clinical Oncology , Presentation Details , Sacituzumab Govitecan , Metastatic Triple Negative Breast Cancer , Updated Phase , Efficacy Results , Private Securities Litigation Reform Act , Investor Relations ,

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology Meeting

G1 Therapeutics, Inc. announced that mature Phase 2 results describing the positive impact of trilaciclib administered in combination with the TROP2 antibody-drug conjugate sacituzumab govitecan on. ....

United States , American Society Of Clinical Oncology , Therapeutics Inc , Clinical Oncology , Presentation Details , Trilaciclib Combined , Sacituzumab Govitecan , Metastatic Triple Negative Breast Cancer , Updated Phase , Efficacy Results Seneviratne , Breast Cancer Metastatic June ,

CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting

Oral presentation in "Developmental Therapeutics-Immunotherapy" session on Sunday, June 2, 2024, at 11:30 AM CDT CatalYm today announced that positive new follow-up results from its ongoing "GDFATHER" ....

Mccormick Place , United States , Phil Lhuilier , Ignacio Melero Bermejo , Catalym Gmb , Alison Opalko , Trophic Communications , Oncology Congress , American Society Of Clinical Oncology , Ted Human Effector Cell Relocation Phase , American Society , Clinical Oncology , Annual Meeting , Growth Differentiation , Presentation Details , Universidad De Navarra , Demand Mccormick Place , Ted Human Effector , Relocation Phase , Phill Huilier , Stephanie May , Ihr Portfolio ,

CellFE Announces Presentations at Upcoming International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting

/PRNewswire/ CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy manufacturing, announced today. ....

British Columbia , International Society Of Gene Cell Therapy , Prnewswire Cellfe Inc , International Society , Cell Therapy , Presentation Details , Microfluidics Approach , Advance Innovative Cell Therapy Manufacturing , Alla Zamarayeva , Exhibit Hall , Human Primary Restingt Cell Manufacturing , Microfluidic Transfection Platform , Poster Networking Reception , Gene Editing , Gene Therapies ,

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting

RESEARCH TRIANGLE PARK, N.C., May 23, 2024 G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that mature Phase 2 results describing the positive impact of trilaciclib. ....

United States , Therapeutics Inc , American Society Of Clinical Oncology , Exchange Commission , Research Triangle Park , Corporate Communications , Clinical Oncology , Presentation Details , Sacituzumab Govitecan , Metastatic Triple Negative Breast Cancer , Updated Phase , Efficacy Results , Private Securities Litigation Reform Act , Investor Relations ,